InvestorsHub Logo
Followers 3
Posts 292
Boards Moderated 0
Alias Born 12/21/2022

Re: Zeppo post# 386

Wednesday, 05/31/2023 5:06:36 PM

Wednesday, May 31, 2023 5:06:36 PM

Post# of 572
Most important is what FDA told them about registrational trial(s). New responses in mono and combo arms of APTIVATE trial could be helpful. Unfortunately, R/S could mute any good news from Tusp program. Unless ORR in combo arm is 100%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News